AstraZeneca reviews

NIH guidelines limits dosing for approval for Insurance. In the past you had to hunt and over track your sales or you wouldn't get credit for the sale.

High pressure in the manufacturing departments to hit targets, the company let far to many people leave on voluntary redundancy and have been paying the price for it. No real career prospects are available for the shop floor operators to progress - no succession planning is in place. poor reward system currently being used where any bonus or salary increase is approved by your manager who if you have a poor relationship with them have the final say in your reward so you will never receive a fare reward package.